Document:

EXHIBIT 10.2
                                                                    ------------

                                                      Grant Date: April 26, 2004

                                  Stock Option

                                   Granted by

                             Able Laboratories, Inc.

                                       To

                                   Garth Boehm

            For valuable consideration, the receipt of which is hereby
acknowledged, Able Laboratories, Inc., a Delaware corporation (hereinafter
together with its subsidiaries, where the context permits, referred to as the
"Company"), hereby grants to the Holder named in Schedule A attached hereto the
following Incentive Stock Option:

            Section 1. Grant of Option. Subject to the terms and conditions
hereinafter set forth, the Holder is hereby given the right and option to
purchase from the Company shares of the Company's Common Stock, $.01 par value
per share (the "Common Stock"). Schedule A attached hereto and hereby
incorporated herein sets forth with respect to this option (i) its expiration
date, (ii) its exercise price per share, (iii) the maximum number of shares that
the Holder may purchase upon exercise hereof, (iv) the vesting schedule, and (v)
certain other terms and conditions applicable to this option and incorporated
herein. This option shall terminate in all respects, and all rights and options
to purchase shares hereunder shall terminate, ten years from the Grant Date set
forth above. The right to purchase shares hereunder shall be cumulative.

            This Option is not issued under the Company's 2003 Stock Incentive
Plan (the "Plan"). However, this Option shall be subject in every respect to the
provisions of the Plan, as the same may be amended from time to time, as fully
if this Option were issued under the Plan. A copy of the Plan is being delivered
herewith, and the Plan is hereby incorporated herein by reference and made a
part hereof. In the event of any conflict or inconsistency between the terms of
this Option and those of the Plan, the terms of the Plan shall govern.

            Section 2. Exercise of Option. This option shall be exercised by the
delivery of written notice to the Company (the "Notice") setting forth the
number of shares with respect to which the option is to be exercised and the
address to which the certificates for such shares are to be mailed, together
with (i) delivery of a personal, certified or bank check or postal money order
payable to the order of the Company for an amount equal to the option price for
the number of shares specified in the Notice, or (ii) with the consent of the
Committee, shares of Common Stock of the Company which (a) either have been
owned by the Holder for more than six (6) months and are not subject to
restrictions under any Plan on the date of surrender or were not acquired,
directly or indirectly, from the Company, and (b) have a fair market value on
the date of surrender not greater than the option price for the shares as to
which such option is being exercised, or (iii) with the consent of the
Committee, delivering to the Company a properly

                                       -1-
<PAGE>

executed Notice together with irrevocable instructions to a broker to promptly
deliver to the Company cash or a check payable and acceptable to the Company to
pay the purchase price; provided that in the event the Holder chooses to pay the
purchase price as so provided, the Holder and the broker shall comply with such
procedures and enter into such agreement of indemnity and other agreements as
the Committee shall prescribe as a condition of such payment procedure; provided
that the Company need not act upon such Notice until the Company receives full
payment of the exercise price, or (iv) with the consent of the Committee, any
combination of such methods of payment. For the purpose of the preceding
sentence, the fair market value per share of the Common Stock so delivered to
the Company shall be the closing price per share on the date of delivery as
reported by the Nasdaq Stock Market, Inc. ("Nasdaq") or another automated
quotation system of the National Association of Securities Dealers, Inc. (the
"NASD"), including the OTC Bulletin Board or any successor thereto or, if the
Common Stock is not then quoted on Nasdaq or any such automated quotation
system, on such registered national securities exchange on which the Common
Stock is listed; provided, that, if there is no trading on such date, the fair
market value shall be deemed to be the closing price per share on the last
preceding date on which the Common Stock was traded. If the Common Stock is not
listed on any national registered securities exchange or quoted on Nasdaq or any
sich automated quotation system, the fair market value of the Common Stock shall
be determined in good faith by the Committee.

            Section 3. Conditions and Limitations. The Company, in its
discretion, may file a registration statement on Form S-8 under the Securities
Act of 1933, as amended (the "Securities Act") to register shares of Common
Stock reserved for issuance under this Option. At any time at which such a
registration statement is not in effect, it shall be an additional condition
precedent to any exercise of this option that the Holder shall deliver to the
Company a customary "investment letter" satisfactory to the Company and its
counsel in which, among other things, the Holder shall state that the Holder is
purchasing the shares for investment and acknowledges that they are not freely
transferable except in compliance with state and federal securities laws.

            Section 4. Delivery of Shares. Within a reasonable time after
receipt by the Company of the Notice and payment for any shares to be purchased
hereunder and, if required as a condition to exercise, the investment letter
described in Section 3, the Company will deliver or cause to be delivered to the
Holder (or if any other individual or individuals are exercising this option, to
such individual or individuals) at the address specified in the Notice a
certificate or certificates for the number of shares with respect to which the
option is then being exercised, registered in the name or names of the
individual or individuals exercising the option, either alone or jointly with
another person or persons with rights of survivorship, as the individual or
individuals exercising the option shall prescribe in writing to the Company at
or prior to such purchase; provided, however, that if any law or regulation or
order of the Securities and Exchange Commission or other body having
jurisdiction in the premises shall require the Company or the Holder (or the
individual or individuals exercising this option) to take any action in
connection with the shares then being purchased, the date for the delivery of
the certificates for such shares shall be extended for the period necessary to
take and complete such action, it being understood that the Company shall have
no obligation to take and complete any such action. The Company may imprint upon
such certificate the legend set forth in the Plan or such other legends
referencing stock transfer restrictions which counsel for the Company considers
appropriate. Delivery by the Company of the certificates for such shares shall
be deemed effected for all purposes when the Company or a stock transfer agent
of the Company shall have deposited such certificates in the United States mail,
addressed to the Holder, at the address specified in the Notice.

                                       -2-
<PAGE>

            Section 5. Adjustments Upon Changes in Capitalization. The existence
of this option shall not affect in any way the right or power of the Company or
its stockholders to make or authorize any or all adjustments, recapitalizations,
reorganizations or other changes in the Company's capital structure or its
business, or any merger or consolidation of the Company, or any issue of Common
Stock, or any issue of bonds, debentures, preferred or prior preference stock or
other capital stock ahead of or affecting the Common Stock or the rights
thereof, or the dissolution or liquidation of the Company, or any sale or
transfer of all or any part of its assets or business, or any other corporate
act or proceeding, whether of a similar character or otherwise.

            If the Company shall effect a stock dividend, stock split or similar
change in capitalization affecting the shares of Common Stock outstanding, in
any such case without receiving compensation therefor in money, services or
property, then the number, class, and price per share of shares of Common Stock
subject to this option shall be appropriately adjusted in such a manner as to
entitle the Holder to receive upon exercise of this option, for the same
aggregate cash consideration, the same total number and class of shares as the
Holder would have received as a result of the event requiring the adjustment had
the Holder exercised this option in full immediately prior to such event.

            Except as hereinbefore expressly provided, the issue by the Company
of shares of stock of any class, or securities convertible into shares of stock
of any class, for cash or property, or for labor or services, either upon direct
sale or upon the exercise of rights or warrants to subscribe therefor, or upon
the conversion of shares or obligations of the Company convertible into such
shares or other securities, shall not affect, and no adjustment by reason
therefor shall be made with respect to, the number or price of shares of Common
Stock then subject to option.

            Section 6. Effect of Certain Transactions. After a merger of one or
more corporations with or into the Company or after a consolidation of the
Company and one or more corporations in which the stockholders of the Company
immediately prior to such merger or consolidation own after such merger or
consolidation shares representing at least fifty percent (50%) of the voting
power of the Company or the surviving or resulting corporation, as the case may
be, the Holder shall, at no additional cost, be entitled upon exercise of this
option to receive in lieu of the shares of Common Stock as to which this option
was exercisable immediately prior to such event, the number and class of shares
of stock or other securities, cash or property (including, without limitation,
shares of stock or other securities of another corporation or Common Stock) to
which the Holder would have been entitled pursuant to the terms of the agreement
of merger or consolidation if, immediately prior to such merger or
consolidation, the Holder had been the holder of record of a number of shares of
Common Stock equal to the number of shares for which this option shall be so
exercised.

            If the Company is merged with or into or consolidated with another
corporation, other than a merger or consolidation in which the stockholders of
the Company immediately prior to such merger or consolidation continue to own
after such merger or consolidation shares representing at least fifty percent
(50%) of the voting power of the Company or the surviving or resulting
corporation, as the case may be, or if the Company is liquidated, or sells or
otherwise disposes of substantially all its assets to another corporation while
this option remains outstanding, then (i) subject to the provisions of clause
(iii) below, after the effective date of such

                                       -3-
<PAGE>

merger, consolidation, liquidation, sale or disposition, as the case may be, the
Holder of this option shall be entitled, upon exercise of this option, to
receive, in lieu of the shares of Common Stock as to which this option was
exercisable immediately prior to such event, the number and class of shares of
stock or other securities, cash or property (including, without limitation,
shares of stock or other securities of another corporation or Common Stock) to
which the Holder would have been entitled pursuant to the terms of the merger,
consolidation, liquidation, sale or disposition if, immediately prior to such
event, the Holder had been the holder of a number of shares of Common Stock
equal to the number of shares as to which such option shall be so exercised;
(ii) the Committee may accelerate the time for exercise of this option, so that
from and after a date prior to the effective date of such merger, consolidation,
liquidation, sale or disposition, as the case may be, specified by the
Committee, such accelerated options shall be exercisable in full; or (iii) this
option may be canceled by the Committee as of the effective date of any such
merger, consolidation, liquidation, sale or disposition provided that (x) notice
of such cancellation shall be given to the Holder and (y) the Holder shall have
the right to exercise this option to the extent that the same is then
exercisable or, if the Committee shall have accelerated the time for exercise of
this option pursuant to clause (ii) above, in full during the 10-day period
preceding the effective date of such merger, consolidation, liquidation, sale or
disposition.

            Section 7. Rights of Holder. No person shall, by virtue of the
granting of this option to the Holder, be deemed to be a holder of any shares
purchasable under this option or to be entitled to the rights or privileges of a
holder of such shares unless and until this option has been exercised with
respect to such shares and they have been issued pursuant to that exercise of
this option.

            The Company shall, at all times while any portion of this option is
outstanding, reserve and keep available, out of shares of its authorized and
unissued stock or reacquired shares, a sufficient number of shares of its Common
Stock to satisfy the requirements of this option; shall comply with the terms of
this option promptly upon exercise of the option rights; and shall pay all fees
or expenses necessarily incurred by the Company in connection with the issuance
and delivery of shares pursuant to the exercise of this option.

            Section 8. Transfer and Termination. This option is not transferable
by the Holder otherwise than by will or under the laws of descent and
distribution. The granting of this option shall not impose upon the Company any
obligation to employ or to continue to employ the Holder. The right of the
Company to terminate the employment of the Holder shall not be diminished or
affected by reason of the fact that this option has been granted to such Holder.

            This Option is exercisable, during the Holder's lifetime, only by
the Holder, and by the Holder only while the Holder is an employee of the
Company, except that if the Holder's employment by the Company terminates for
any reason other than death, Disability (as defined in the Plan) or for Cause,
the Holder shall have the right to exercise this Option within thirty (30) days
after the date of such termination of employment (but not later than the
expiration date of this Option) with respect to shares which were purchasable by
the Holder by exercise of this Option at the time of said termination of
employment.

            As used herein, "Cause" shall mean (x) any material breach by the
Holder of any agreement to which the Holder and the Company (or any parent or
subsidiary) are both parties, (y) any act (other than retirement) or omission to
act by the Holder which may have a material

                                       -4-
<PAGE>

and adverse effect on the business of the Company (or any parent or subsidiary)
or on the Holder's ability to perform services for the Company (or any parent or
subsidiary), including, without limitation, the commission of any crime (other
than ordinary traffic violations), or (z) any material misconduct or material
neglect of duties by the Holder in connection with the business or affairs of
the Company (or any parent or subsidiary) or any affiliate of the Company (or
any such parent or subsidiary).

            In the event of the death or Disability of the Holder while the
Holder is in the employ of the Company (or any parent or subsidiary of the
Company) and before the expiration date of this option, this option shall
terminate on the earlier of its expiration date or a date one (1) year after the
date of his death or Disability. After the death of the Holder, the Holder's
executors, administrators or any person or persons to whom the Holder's option
has been transferred by will or by the laws of descent and distribution shall
have the right to exercise this option at any time prior to the earlier of the
date of expiration of this option or one (1) year after the date of the death of
the original Holder.

            Section 9. Notification of Disqualifying Disposition. The Holder
agrees to notify the Company in writing immediately after making a Disqualifying
Disposition of any shares of Common Stock received pursuant to the exercise of
this Option. The Holder also agrees to provide the Company with any information
that the Company shall request concerning any such Disqualifying Disposition.

                        9.1 Disqualifying Disposition. A "Disqualifying
Disposition" shall have the meaning specified in Section 421(b) of the Internal
Revenue Code of 1986, as amended, or any successor provision; as of the date of
grant of this Option, a Disqualifying Disposition is any disposition (including
any sale) of such shares before the later of (a) the second anniversary of the
date of grant of this Option or (b) the first anniversary of the date on which
the Holder acquired such shares by exercising this Option, provided that such
holding period requirements terminate upon the death of the Holder.

                        9.2 Forfeiture of Favorable Tax Treatment. The Holder
acknowledges that he or she will forfeit the favorable income tax treatment
otherwise available with respect to the exercise of this Option if he or she
makes a Disqualifying Disposition of shares received upon exercise of this
Option.

            Section 10.  Withholding of Taxes.

                        10.1 Election as to Method of Satisfying Withholding
Obligation. At the Holder's election, the amount required to be withheld may be
satisfied, in whole or in part, by (a) authorizing the Company to withhold from
shares of Common Stock to be issued pursuant to the exercise of such
Non-Statutory Option a number of shares with an aggregate fair market value that
would satisfy the minimum withholding amount due with respect to such exercise,
or (b) transferring to the Company shares of Common Stock that have been
purchased by the Holder on the open market or have been beneficially owned by
the Holder for a period of at least six months and are not then subject to
restrictions under any Plan and with an aggregate fair market value that would
satisfy the minimum withholding amount due.

                        10.2 Agreement to Reimburse Company for Withholding
Obligation. The Company shall have the right to deduct from payments of any kind
otherwise due to the Holder

                                       -5-
<PAGE>

any federal, state or local taxes of any kind required by law to be withheld
with respect to shares issued upon exercise of this Option. Prior to delivery of
any Common Stock pursuant to the terms of this Option, the Board has the right
to require that the Holder remit to the Company an amount sufficient to satisfy
any minimum tax withholding obligation.

            Section 11. Notice. Any notice to be given to the Company hereunder
shall be deemed sufficient if addressed to the Company and delivered by hand or
by mail to the Chief Financial Officer of the Company, 6 Hollywood Court, South
Plainfield, New Jersey 07080 or such other address as the Company may hereafter
designate.

            Any notice to be given to the Holder hereunder shall be deemed
sufficient if addressed to and delivered in person to the Holder or when
deposited in the mail, postage prepaid, addressed to the Holder at the Holder's
address furnished to the Company.

            Section 12. Government and Other Regulations. This option is subject
to all laws, regulations and orders of any governmental authority which may be
applicable thereto and, notwithstanding any of the provisions hereof, the Holder
agrees that the Holder will not exercise the option granted hereby nor will the
Company be obligated to issue or sell any shares of stock hereunder if the
exercise thereof or the issuance or sale of such shares, as the case may be,
would constitute a violation by the Holder or the Company of any such law,
regulation or order or any provision thereof. The Company shall not be obligated
to take any affirmative action in order to cause the exercise of this option or
the issuance or sale of shares pursuant hereto to comply with any such law,
regulation, order or provision.

            Section 13. Governing Law. This option shall be governed by, and
construed and enforced in accordance with, the substantive laws of the State of
Delaware.

                 [Remainder of page intentionally left blank.]

                                       -6-
<PAGE>

            IN WITNESS WHEREOF, the Company has caused this instrument to be
executed in its name and on its behalf as of the date first written above.

                                            Able Laboratories, Inc.

                                            By: /s/ Dhananjay G. Wadekar
                                                ---------------------------

                                            Its: Chief Executive Officer
                                                 --------------------------

                                       -7-
<PAGE>

                                   Schedule A
                             Able Laboratories, Inc.

                                  Stock Option
                                  ------------

Date of Grant:                                 April 26, 2004

Name of Holder:                                Garth Boehm

Address:                                       ____________
                                               ____________

Social Security Number:                        ____________

Maximum number of shares for which
this Option is exercisable:                    100,000

Exercise (purchase) price per share:           $19.16

Expiration date of this Option:                April 26, 2014

Vesting schedule:                              25,000 upon the first anniversary
                                               of start of employment, 12,500
                                               upon each of the 18 and 24 month
                                               anniversaries of start of
                                               employment, and the balance in
                                               eight (8) equal quarterly
                                               installments of 6,250 each on the
                                               last day of each calendar quarter
                                               thereafter.

Other terms and conditions: (1) The Holder agrees that in the event of the
filing of a registration statement under the Securities Act by the Company, upon
request of the Company or the underwriters managing any underwritten offering of
the Company's securities, the Holder shall agree in writing that for a period of
time not to exceed one hundred eighty (180) days from the effective date of any
registration of securities of the Company the Holder will not sell, make any
short sale of, loan, grant any option for the purchase of, or otherwise dispose
of any shares of Common Stock issued pursuant to the exercise of this option
without the prior written consent of the Company or such underwriters, as the
case may be.

The undersigned Holder acknowledges receipt of the stock option of which this
Schedule A is a part.

                                                     /s/Garth Boehm
                                                     --------------------------
                                                     Holder's Signature
                                                     Print Name: Garth Boehm

                                       -8-EXHIBIT 10.3
                                                                    ------------

                              EMPLOYMENT AGREEMENT

     AGREEMENT made as of the 26th day of April, 2004, by and between Able
Laboratories, Inc., a Delaware corporation, with its principal office in
Needham, Massachusetts (the "Company"), and Robert Mauro of Miller, New York
(the "Executive").

                                   WITNESSETH

     WHEREAS, the Corporation and the Executive desire to set forth the terms
and conditions on which, from and after the Effective Date, (i) the Corporation
shall employ the Executive, (ii) the Executive shall render services to the
Corporation, and (iii) the Corporation shall compensate the Executive for such
services;

     NOW THEREFORE, in consideration of the mutual covenants contained herein,
the Company and the Executive (individually a "Party" and together the
"Parties") agree as follows:

     1. Employment

          1.1. Term of Employment. This Agreement will be effective on the day
the Executive begins employment (the "Effective Date") and end at the close of
business on the fifth anniversary of the Effective Date (the "Initial Term");
provided, however, that the Initial Term shall thereafter be automatically
extended for additional one-year periods (together with the Initial Term, the
"Term") unless either the Company or the Executive gives the other written
notice at least 120 days prior to the then-scheduled expiration of the Term that
such Party is electing not to so extend the Term. Notwithstanding the foregoing,
the Term shall end on the date on which the Executive's employment is terminated
by either Party in accordance with the provisions herein.

          1.2. Title and Responsibilities. The Executive shall serve the Company
in a senior executive capacity, initially as President and Chief Operating
Officer. In such positions, the Executive shall have the duties,
responsibilities and authorities as determined and designated from time to time
by the Chief Executive Officer and Board of Directors of the Company, including,
without limitation, management authority with respect to, and direct
responsibility for all of the Company's operations in the areas of
manufacturing, quality control (which currently includes regulatory affairs) and
quality assurance, sales, marketing, shipping, warehousing, and human resources,
as well as assisting the Chief Executive Officer in all other activities
including, without limitation, research and development (which will include
regulatory affairs), business development, finance and accounting. The Executive
shall serve under the direction and supervision of, and report to, the Chief
Executive Officer and shall be a member of the Product Selection Committee.
Notwithstanding the above, the Executive shall not be required to perform any
duties and responsibilities which would result in noncompliance with or
violation of any applicable law or regulation.

          1.3. Nomination to Board of Directors. The Company shall cause the
Executive to be appointed to the Board of Directors upon the Effective Date, and
shall cause the Executive to be nominated for election to the Company's Board of
Directors during the term, subject at all times to the Company's obligations
under applicable laws and regulations, including without limitation Rule 4350 of
the Marketplace Rules of the Nasdaq Stock Market, Inc.

<PAGE>

     2. Compensation and Benefits. The compensation and benefits payable to the
Executive under this Agreement shall be as follows:

          2.1. Salary. For all services rendered by the Executive to the
Company, the Executive shall be entitled to receive a base salary ("Base
Salary") at the rate of $350,000 per year beginning as of the Effective Date.
The Executive's Base Salary shall be reviewed annually by the Compensation
Committee of the Board of Directors, with the first review to occur in or around
January 2005, and shall be subject to increase from time to time as approved by
the Compensation Committee of the Board of Directors. In addition, if the
Compensation Committee of the Board of Directors increases the Executive's
annual base salary, such increased annual Base Salary shall become a floor below
which such annual Base Salary shall not fall (other than concurrently with
across-the-board salary reductions based on the Company's financial performance
similarly affecting all senior management personnel of the Company) without the
Executive's written consent. The Executive's salary shall be payable in periodic
installments in accordance with the Company's usual practice for its senior
executives.

          2.2. Initial Bonus. The Company shall pay the Executive a bonus of
$100,000 to be paid at commencement of employment; provided, that if the
Executive terminates his employment voluntarily before the first anniversary of
the Effective Date then the Executive shall repay an amount pro-rated
proportionally to the percentage of the first year of employment not completed.

          2.3. Performance Bonus. The Executive shall be eligible to earn a
bonus of opportunity equal to at least the greater of (i) 50% of his Base Salary
or (ii) $200,000, based on achievement of pre-determined objectives set by the
Compensation Committee. The Compensation Committee of the Board of Directors
shall determine, on an annual basis, the amount of any bonus to be paid to the
Executive for such year and the Executive's performance objectives for the
upcoming year; provided however the bonus for 2004 will be guaranteed to be no
less than $200,000.

          2.4. Reimbursement for Certain Expenses. The Executive shall be paid a
monthly stipend of $2,000 for expense associated with the purchase, or lease,
and use of an automobile. The Executive shall comply with such reasonable
reporting on the use of the automobile as may be established from time to time
by the Company. The Company shall also reimburse the Executive for expenses and
dues for one country club membership, as well as ongoing reasonable fees and
expenses and per diems relating thereto, subject to such reasonable requirements
with respect to substantiation and documentation as may be specified by the
Company. The Company shall include annually on the Executive's Form W-2 any
amounts associated with the foregoing as may be required by law.

          2.5. Stock Option Grant. As of the date hereof the Company is granting
to the Executive an option to purchase up to 300,000 shares of Common Stock,
pursuant to the terms of the Stock Option Agreement attached hereto as Exhibit
A. The Executive will also participate in stock option or other long term
incentive programs for senior management, as determined by Compensation
Committee in its discretion.

                                       -2-
<PAGE>

          2.6. Benefits. The Executive shall also be entitled to participate in
any and all employee benefit plans, medical insurance plans, disability income
plans, retirement plans, bonus incentive plans, and other benefit plans from
time to time in effect for senior executives of the Company, including long-term
care insurance coverage which the Company shall obtain for its senior executives
as soon as is reasonably practicable but in no event later than December 31,
2004. The Company will pay the premiums as may be necessary to maintain the
Executive's coverage under his current employer's health insurance plans until
such time as the Executive is eligible to participate under the Company's plans.
Such participation shall be subject to (i) the terms of the applicable plan
documents, (ii) generally applicable policies of the Company and (iii) the
discretion of the Board of Directors of the Company or any administrative or
other committee provided for in or contemplated by such plan. The Executive and
his spouse will be entitled to receive annual health exams ("Platinum Plan" or
equivalent).

          2.7. Life Insurance. The Company will obtain two life insurance
policies covering the Executive, subject to the Executive's application for
coverage and passing a physical examination, with a death benefit under each
policy equal to two (2) years' Base Salary, one of which shall be payable to
Company and one payable to Executive's estate.

          2.8. Business Expenses. The Company shall reimburse the Executive for
all reasonable travel and other business expenses incurred by the Executive in
the performance of his duties and responsibilities, including, without
limitation, expenses related to temporary living, including hotel or furnished
apartment rental with utilities in South Plainfield or Cranbury, New Jersey, in
accordance with Company policies and procedures and subject to such reasonable
requirements with respect to substantiation and documentation as may be
specified by the Company.

          2.9. Vacation. The Executive shall be entitled to not less than twenty
(20) working days of vacation per year, to be taken at such times and intervals
as shall be determined by the Executive consistent with his responsibilities.

          2.10. General. Nothing paid to the Executive under any plan, policy or
arrangement currently in effect or made available in the future shall be deemed
to be in lieu of other compensation to the Executive as described in this
Agreement.

     3. Service

          3.1. Extent of Service. The Executive shall, subject to the direction
and supervision of the Board of Directors, devote his full time, best efforts
and business judgment, skill and knowledge to the advancement of the Company's
interests and to the discharge of his duties and responsibilities hereunder;
provided, however, that nothing herein shall be construed as preventing the
Executive from:

               (a) investing his assets in such form or manner as shall not
require any material services on his part in the operations or affairs of the
companies or the other entities in which such investments are made;

               (b) serving on the board of directors of another business
corporation, provided that he obtains the prior approval of a majority of the
Board of Directors and shall not be

                                      -3-
<PAGE>

required to render any material services with respect to the operations or
affairs of such company; or

               (c) serving on the boards of trade associates or charitable
organizations or engaging in religious, charitable or other community or
non-profit activities which do not impair his ability to fulfill his duties and
responsibilities under this Agreement.

          3.2. Location of Service. The Executive shall carry out his duties in
the Company's facilities as designated by the Board of Directors, and shall
initially have his primary office in the Company's offices in South Plainfield,
New Jersey or Cranbury, New Jersey. The Executive acknowledges that his position
will also require extensive travel. The Board of Directors may re-evaluate the
locations of the Company's offices from time to time.

     4. Termination by the Company for Cause

          4.1. Termination by Company. The Executive's employment hereunder may
be terminated by the Company, without further liability on the part of the
Company, effective immediately, by the Board of Directors for Cause (as such
term is defined in Section 4.2) by written notice to the Executive setting forth
in reasonable detail the nature of such Cause, provided that the Board of
Directors have complied with the provisions of Section 4.3.

          4.2. Cause. Termination for "Cause" shall mean:

               (a) gross neglect of duties for which employed (other than on
account of a medically determinable disability which renders the Executive
incapable of performing such services);

               (b) committing fraud, misappropriation or embezzlement in the
performance of duties as an employee of the Company;

               (c) conviction of a felony involving a crime of moral turpitude;
or

               (d) willfully engaging in conduct materially injurious to the
Company in violation of the covenants contained in this Agreement.

          4.3. Termination Procedure. In each case, in determining Cause the
alleged acts or omissions of the Executive shall be measured against standards
prevailing in the industry generally and the ultimate existence of Cause must be
confirmed by not less than two-thirds of the Board of Directors (excluding the
Executive) at a meeting prior to any termination therefor; provided, however,
that it shall be the Company's burden to prove the alleged facts and omissions
and the prevailing nature of the standards the Company shall have alleged are
violated by such acts or omissions of the Executive. In the event of such a
confirmation by two-thirds or more of the Board of Directors, the Company shall
notify the Executive that the Company intends to terminate the Executive's
employment for Cause under this Section 4 (the "Confirmation Notice"). The
Confirmation Notice shall specify the acts or omissions upon the basis of which
the Board of Directors have confirmed the existence of Cause and must be
delivered to the Executive within ninety (90) days after a majority of the Board
of Directors (excluding, if applicable, the Executive) has actual knowledge of
the events giving rise to such

                                       -4-
<PAGE>

purported termination. The Confirmation Notice shall also specify the date
(which shall not be earlier than the date of the Conformation Notice.) If the
Executive notifies the Company in writing (the "Opportunity Notice") within
thirty (30) days after the Executive has received the Confirmation Notice, the
Executive (together with counsel) shall be provided one opportunity to meet with
the Board of Directors (or a sufficient quorum thereof) to discuss such acts or
omissions. Such opportunity to meet with the Board of Directors shall be fixed
and shall occur on a date selected by the Board of Directors (such date being
not less than ten (10) nor more than forty-five (45) days after the Company
receives the Opportunity Notice from the Executive). Such meeting shall take
place at the principal offices of the Company or such other location as agreed
to by the Executive and the Company. During the period commencing on the
effective date of the termination and ending on the date next succeeding the
date on which such meeting between the Board of Directors (or a sufficient
quorum thereof) and the Executive is scheduled to occur and notwithstanding
anything to the contrary in this Agreement, the Executive shall be suspended
from employment with the Company (with pay to the extent not prohibited by
applicable law). If the Board of Directors properly set the date of such meeting
and if the Board of Directors (or a sufficient quorum thereof) attends such
meeting and in good faith does not rescind its confirmation of Cause at such
meeting or if the Executive fails to attend such meeting for any reason other
than Disability (as defined in Section 8), the Executive's employment by the
Company shall, immediately upon the closing for such meeting and the delivery to
the Executive of the Notice of Termination, be terminated for Cause. If the
Executive does not respond in writing to the Confirmation Notice in the manner
and within the time period specified in this Section 4.3, the Executive's
employment with the Company shall, on the thirty-first day after the receipt by
the Executive of the Confirmation Notice, be terminated for Cause under this
Section 4 effective as of the date specified in the Confirmation Notice.

          4.4. Termination of Obligations. In the event of termination pursuant
to this Section 4, all obligations of the Company under this Agreement, other
than the Company's obligations under the provisions of COBRA, shall terminate as
of the date specified in the Confirmation Notice, but vested rights of the
parties hereunder as of such date shall not be affected. Any vested options held
by the Executive shall terminate upon termination pursuant to this Section 4,
and any unvested options shall be forfeited and expire as of the date of
termination.

     5. Termination by the Executive

          5.1. Termination by the Executive for Good Reason. The Executive shall
be entitled to terminate his employment hereunder for Good Reason (as defined in
Section 5.3) effective immediately by giving written notice to the Board of
Directors. Upon any such termination, the Executive shall be entitled to receive
the benefits set forth in Section 7.

          5.2. Other Voluntary Termination by the Executive. The Executive may
effect, upon thirty (30) days prior written notice to the Company, a Voluntary
Termination of his employment hereunder. A "Voluntary Termination" shall mean a
termination of employment (including an election not to renew this Agreement
upon expiration of the Term) by the Executive on his own initiative other than a
termination for Good Reason or due to Disability (as defined in Section 8). If
the Executive's employment is so terminated due to Voluntary Termination, the
Executive shall be entitled to Base Salary up to the date of termination.
Provision of medical benefits shall be in accordance with the provisions of
COBRA.

                                       -5-
<PAGE>

Furthermore, any vested options held by the Executive shall expire on the
ninetieth (90th) day following termination, and any unvested options shall be
forfeited and expire as of the date of termination.

          5.3. Good Reason. For purposes of this Agreement, the term "Good
Reason" shall mean any of the following:

               (a) a material diminution in Executive's title or duties;

               (b) the failure of the Nominating Committee of the Board of
Directors to nominate Executive for election or re-election to the board of
directors;

               (c) a reduction in his then current salary or target bonus
opportunity as a percentage of salary except for across the board cuts
applicable to senior management;

               (d) a change in the reporting structure so that Executive no
longer reports directly to CEO;

               (e) relocation of Executive's principal place of employment to a
location other than the South Plainfield or Cranbury, New Jersey area;

               (f) a material breach by the Company of any provisions of this
Agreement which failure or breach shall have continued for thirty (30) days
after written notice from the Executive to the Company specifying the nature of
such failure or breach; or

               (g) in the event of a Change in Control of the Company, if either
the Company fails to obtain the assumption in writing of its successor to
perform its obligations under this Agreement or if the Executive is not offered
a position of equal or greater responsibility in the resulting or surviving
entity.

               (h) There shall be no termination for Good Reason without written
notice from Executive describing the basis for the termination and the Company's
having 60 days in which to cure.

     6. Termination by the Company Without Cause. The Executive's employment
with the Company may be terminated (including by an election not to renew this
Agreement upon expiration) without cause by a majority of the Board of Directors
of the Company on written notice to the Executive, provided, however, that the
Company shall have the obligation upon any such termination to make the payments
to the Executive provided for under Section 7 of this Agreement.

     7. Certain Termination Benefits. In the event of termination pursuant to
Section 5.1 or 6, the Executive shall be entitled to each of the following
benefits:

          7.1. Earnings to Date of Termination. An amount equal to the sum of
(a) Base Salary or other compensation earned through the date of termination,
plus (b) the Executive's pro rata share (based on the portion of the fiscal year
during which the Executive was employed) of the larger of: (i) the highest
annual bonus paid during the three fiscal years preceding the

                                       -6-
<PAGE>

termination of employment or (ii) twenty percent (20%) of the Executive's
current Annual Compensation (as defined below) (together, "Pre-Termination
Compensation").

          7.2. Lump Sum Severance Payment. A lump sum severance benefit equal to
the Executive's current Annual Compensation. "Annual Compensation" shall equal
the aggregate of the Executive's then current Base Salary plus any bonuses
earned or accrued with respect to the most recently ended fiscal year, together
with any contributions or accruals made on behalf of Executive to any profit
sharing plan or pension or retirement plan, by the Company for the benefit of
the Executive for the most recently ended fiscal year.

          7.3. Option Acceleration and Exercise. Fifty percent (50%) of the
Executive's unvested options will vest, and all vested options held by the
Executive will remain exercisable for a period ending on the first anniversary
of termination.

          7.4. Benefit Continuation. For the twelve (12) month period subsequent
to the date of termination, the Executive shall continue to receive the
disability and medical benefits described in Section 2.6 existing on the date of
termination at the level in effect on, and at the same out-of-pocket cost to the
Executive as of, the date of termination, provided that the right to receive
such benefits shall terminate upon the Executive's becoming covered under the
disability and medical plans of a new employer. Such medical benefits shall be
deemed to have been provided under the provisions of COBRA.

     8. Death, Disability. The Executive's employment shall terminate
immediately upon the death or Disability of the Executive. "Disability" means
Executive's failure by reason of sickness, accident or physical or mental
disability to substantially perform the duties and responsibilities of his
employment with the Company for a period of sixty (60) consecutive days. In the
event of termination under this Section 8, the Executive or his estate will
receive the Executive's Pre-Termination Compensation as defined in Section 7.1,
and fifty percent (50%) of the Executive's unvested options will vest and all
vested options held by the Executive will remain exercisable for a period ending
of the first anniversary of termination.

     9. Change of Control

          9.1. Definition. A "Change of Control" means (i) the sale of all or
substantially all of the assets or issued and outstanding capital stock of the
Company, (ii) merger or consolidation involving the Company in which
stockholders of the Company immediately before such merger or consolidation do
not own immediately after such merger or consolidation capital stock or other
equity interests of the surviving corporation or entity representing more than
fifty percent in voting power of capital stock or other equity interests of such
surviving corporation or entity outstanding immediately after such merger or
consolidation, or (iii) a change, without the approval of the Board of
Directors, of a majority of the Board of Directors.

          9.2. Option Vesting Acceleration Upon Change of Control. If a Change
of Control occurs while the Executive is employed by the Company, then, whether
or not the Executive is terminated in connection with the Change of Control and
notwithstanding any contrary or inconsistent provision of any option granted to
the Executive by the Company, the unvested options held by the Executive
immediately before such Change of Control shall vest upon such

                                       -7-
<PAGE>

Change of Control and remain exercisable in accordance with the terms of this
Agreement and such options.

          9.3. Section 280G. In the event it shall be determined that any amount
paid to the Executive upon a Change of Control (a "Payment") would be subject to
the excise tax imposed by Section 4999 of the Code (the "Excise Tax"), then the
Executive shall receive an additional payment (a "Gross-Up Payment") in an
amount such that, after payment by the Executive of all taxes, including without
limitation, any income, employment and excise taxes imposed upon the Gross-Up
Payment, the Executive retains an amount of the Gross-Up Payment equal to the
Excise Tax imposed upon the Payment, subject to the following: the Executive
shall not pay any Excise Tax without the prior written consent of the Company,
which shall not be unreasonably withheld (provided that the Company shall pay
any penalty imposed on the Executive because of any delay in paying any Excise
Tax caused solely by the Company's failure to grant its consent), and in the
event that the Executive receives any notice of audit from the Internal Revenue
Service, shall promptly so inform the Company, and shall thereafter cooperate
with the Company in connection with any dispute or other proceedings before the
Internal Revenue Service, any other governmental authority and/or any court
proceedings concerning the assessment of any Excise Tax or the applicability of
Section 4999 to any Payment. The Company shall at its election be entitled to
control the conduct of such a dispute or other proceeding insofar as it relates
to the assessment of any Excise Tax or the applicability of Section 4999 to any
Payment, provided, that the Company shall bear and pay directly all costs and
expenses of such dispute and shall indemnify and hold the Executive harmless for
any Excise Tax imposed on a Payment thereunder.

     10. Confidential Information. The Executive will not disclose to any other
Person (except as required by applicable law or in connection with the
performance of his duties and responsibilities hereunder), or use for his own
benefit or gain, any confidential information of either Company obtained by him
incident to his employment with the Company. The term "confidential information"
includes, without limitation, financial information, technical information,
designs, business plans, customers, vendors, prospects and opportunities (such
as lending relationships, financial product developments, or possible
acquisitions or dispositions of business or facilities) which have been
discussed or considered by the management of the Company but does not include
any information which has become part of the public domain by means other than
the Executive's nonobservance of his obligations hereunder. The provisions of
this Section 10 shall survive for a period of three years following the
termination of this Agreement.

     11. Non-Competition. In the event of termination pursuant to Sections 4.1
or 5.2, the Executive will not, for a period of six (6) months after
termination, directly or indirectly, alone or as a partner, officer, director,
employee, consultant, agent, or independent contractor of any company or
business organization, (a) engage in any business activity which is directly or
indirectly in competition with the business of the Company in the area of
developing, manufacturing, licensing and distributing generic pharmaceutical
drugs ("Competitive Activity") or (b) solicit or contact in connection with, or
in furtherance of, a Competitive Activity any of the Company's employees,
consultants, agents, suppliers, customers, or prospects that were such with
respect to the Company at any time during the one year immediately preceding the
date of termination or that become such with respect to the Company at any time
during the six months

                                       -8-
<PAGE>

immediately following the date of termination; provided, that the Executive's
obligations under this Section 11 shall be subject to the Company's continuing
to pay the Executive his Base Salary during the six-month period. The provisions
of this Section 11 shall survive the termination of this Agreement. The
Executive represents and warrants that the covenant imposed by this Section 9
would not cause him an undue hardship.

     12. No Mitigation; No Offset. In the event of any termination of employment
under this Agreement, the Executive shall be under no obligation to seek other
employment or to mitigate damages, and there shall be no offset against any
amounts due to the Executive under this Agreement for any reason, including,
without limitation, on account of any remuneration attributable to any
subsequent employment that the Executive may obtain. Any amounts due under this
Agreement are in the nature of severance payments or liquidated damages, or
both, and are not in the nature of a penalty.

     13. Specific Performance. The Executive agrees that any breach of Section
10 or 11 of this Agreement by the Executive could cause irreparable damage and
that in the event of such breach the Company shall have, in addition to any and
all remedies available at law or in equity, the right to an injunction, specific
performance or other equitable relief to prevent the violation of the
Executive's obligations hereunder.

     14. Miscellaneous

          14.1. Representations and Covenants. The Executive hereby represents
and warrants that the execution of this Agreement and the performance of his
obligations hereunder will not breach or be in conflict with any other agreement
to which he is a party or is bound, and that he is not now subject to any
covenants against competition or similar covenants which would affect the
performance of his obligations hereunder.

          The Company represents that (i) the execution of this Agreement and
the provision of all benefits and grants provided herein have been duly
authorized by the Company, including, where necessary, by the Board and
Compensation Committee, (ii) the execution, delivery and performance of this
Agreement does not violate any law, regulation, order, decree, agreement, plan
or corporate governance document of the Company and (iii) upon the execution and
delivery of this Agreement, it shall be the valid and binding obligation of the
Company enforceable in accordance with its terms.

          14.2. Definition of "Person." For purposes of this Agreement, the term
"Person" shall mean an individual, a corporation, an association, a partnership,
an estate, a trust and any other entity or organization.

          14.3. Withholding. All payments made by the Company under this
Agreement shall be net of any tax or other amounts required to be withheld by
the Company under applicable law.

          14.4. Indemnification. The Executive shall, as an officer of the
Company, be eligible for indemnification on the terms available to officers and
directors to fullest extent permitted by law and Able's charter and bylaws as in
effect from time to time.

          14.5. Arbitration of Disputes. Any controversy or claim arising out of
or relating to

                                       -9-
<PAGE>

this Agreement or the breach thereof shall be settled by arbitration in
accordance with the laws of the State of New Jersey by three arbitrators, one of
whom shall be appointed by the Company, one by the Executive and the third by
the first two arbitrators. If the first two arbitrators cannot agree on the
appointment of a third arbitrator, then the third arbitrator shall be appointed
by the American Arbitration Association in the City of Newark, New Jersey. Such
arbitration shall be conducted in the City of Newark, New Jersey in accordance
with the rules of the American Arbitration Association, except with respect to
the selection of arbitrators which shall be as provided in this Section 14.5.
Judgment upon the award rendered by the arbitrators may be entered in any court
having jurisdiction thereof.

          14.6. Assignment; Successors and Assigns, etc. Neither the Company nor
the Executive may make any assignment of this Agreement or any interest herein,
by operation of law or otherwise, without the prior written consent of the other
party and without such consent any attempted transfer or assignment shall be
null and of no effect; provided, however, that the Company may assign its rights
under this Agreement without the consent of the Executive in the event either
Company shall hereafter effect a reorganization, consolidate with or merge into
any other Person, or transfer all or substantially all of its properties or
assets to any other Person. This Agreement shall inure to the benefit of and be
binding upon the Company and the Executive, and their respective successors,
executors, administrators, heirs and permitted assigns. In the event of the
Executive's death prior to the completion by the Company of all payments due his
under this Agreement, the Company shall continue such payments to the
Executive's beneficiary designated in writing to the Company prior to his death
(or to his estate, if he fails to make such designation).

          14.7. Enforceability. If any portion or provision of this Agreement
shall to any extent be declared illegal or unenforceable by a court of competent
jurisdiction, then the remainder of this Agreement, or the application of such
portion or provision in circumstances other than those as to which it is so
declared illegal or unenforceable, shall not be affected thereby, and each
portion and provision of this Agreement shall be valid and enforceable to the
fullest extent permitted by law.

          14.8. Waiver. No waiver of any provision hereof shall be effective
unless made in writing and signed by the waiving party. The failure of any party
to require the performance of any term or obligation of this Agreement, or the
waiver by any party of any breach of this Agreement, shall not prevent any
subsequent enforcement of such term or obligation or be deemed a waiver of any
subsequent breach.

          14.9. Notices. Any notices, requests, demands and other communications
provided for by this Agreement shall be sufficient if in writing and delivered
in person or sent by registered or certified mail, postage prepaid, to the
Executive at the last address the Executive has filed in writing with the
Company or, in the case of the Company, at its main office, attention of the
Board of Directors.

          14.10. Amendment. This Agreement may be amended or modified only by a
written instrument signed by the Executive and by a duly authorized
representative of the Company.

          14.11. Governing Law. This contract shall be construed under and be
governed in all respects by the laws of The State of New Jersey.

                                    * * * * *

                                      -10-
<PAGE>

     IN WITNESS WHEREOF, this Agreement has been executed as a sealed instrument
by the Company, by their duly authorized officers, and by the Executive, as of
the date first above written.

                                       Able Laboratories, Inc.

                                       By: /s/Dhananjay G. Wadekar
                                           ----------------------------
                                           Dhananjay G. Wadekar
                                           Chief Executive Officer

                                       /s/Robert J. Mauro
                                       --------------------------------
                                       Robert Mauro

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}]]